Solid Biosciences Inc. (CIK: 0001707502) EDGAR, Information, Filings... CompaniesBIO.Com

Solid Biosciences Inc.

Mailing address
500 RUTHERFORD AVENUE, CHARLESTOWN, Delaware, 02129
Phone
617-337-4680
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Solid Biosciences Inc. (CIK: 0001707502) is an American company incorporated in the state of Massachusetts. Head office is located at 500 RUTHERFORD AVENUE, CHARLESTOWN, Massachusetts, 02129. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Solid Biosciences Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Solid Biosciences, LLC from 2017-04-Aug to 2018-25-Jan

Owner	Filings	Transaction Date	Type of Owner
Brooks Gabriel	0001997809	Oct-18-2023	officer: Chief Medical Officer
Tan Kevin	0001884056	Jan-09-2023	officer: CFO & Treasurer
Keresty Georgia	0001773532	Dec-13-2022	director
Kahn Clare	0001849236	Dec-13-2022	director
SMITH IAN F	0001197032	Dec-02-2022	director
Howton David T	0001529297	Dec-02-2022	officer: See Remarks
Cumbo Alexander	0001685994	Dec-02-2022	director, officer: President and CEO
BCIP Life Sciences Associates, LP	0001702921	Dec-02-2022	10 percent owner
Bain Capital Life Sciences Partners, LP	0001703030	Dec-02-2022	10 percent owner
Bain Capital Life Sciences Investors, LLC	0001703031	Dec-02-2022	10 percent owner
BCLS SB Investco, LP	0001728056	Dec-02-2022	10 percent owner
Perceptive Xontogeny Venture Fund, LP	0001757940	Dec-02-2022	director, 10 percent owner
Bain Capital Life Sciences Fund II, L.P.	0001773187	Dec-02-2022	10 percent owner
RA Capital Nexus Fund, L.P.	0001780117	Dec-02-2022	director, 10 percent owner
Bain Capital Life Sciences Investors II, LLC	0001796155	Dec-02-2022	10 percent owner
BCLS II Investco, LP	0001818893	Dec-02-2022	10 percent owner
BCLS II Investo (GP), LLC	0001819101	Dec-02-2022	10 percent owner
Perceptive Venture Advisors, LLC	0001890130	Dec-02-2022	director, 10 percent owner
Hanrahan Jessie	0001954826	Dec-02-2022	officer: Chief Regulatory Officer
Herzich Paul	0001954991	Dec-02-2022	officer: Chief Technology Officer
Marlowe Jennifer	0001955871	Dec-02-2022	officer: CSO, FA & Cardiac
Brennan Erin Powers	0001764644	Mar-01-2021	officer: Chief Legal Officer, Secretary
DiPalma Stephen J.	0001426479	Jan-29-2021	officer: Interim CFO
RA Capital Healthcare Fund LP	0001315082	Dec-10-2020	director, 10 percent owner
RA CAPITAL MANAGEMENT, L.P.	0001346824	Dec-10-2020	director, 10 percent owner
Kolchinsky Peter	0001384859	Dec-10-2020	director, 10 percent owner
Ultragenyx Pharmaceutical Inc.	0001515673	Oct-22-2020	10 percent owner
LEWIS JOSEPH	0001015747	Mar-04-2019	10 percent owner
Boxer Asset Management Inc.	0001465836	Mar-04-2019	10 percent owner
Boxer Capital, LLC	0001465837	Mar-04-2019	10 percent owner
MVA Investors, LLC	0001468223	Mar-04-2019	10 percent owner
Braslyn Ltd.	0001642355	Mar-04-2019	10 percent owner
HERSCHA LYNETTE	0001708198	Jan-30-2019	officer: See Remarks
Nagendran Sukumar	0001665124	Sep-12-2018	director
Freed Martin I	0001676653	Jun-22-2018	director
JPMORGAN CHASE & CO	0000019617	Jan-25-2018	10 percent owner
EDELMAN JOSEPH	0001164426	Jan-25-2018	10 percent owner
PERCEPTIVE ADVISORS LLC	0001224962	Jan-25-2018	director, 10 percent owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	0001249675	Jan-25-2018	director, 10 percent owner
Koppel Adam	0001578965	Jan-25-2018	director
Shah Rajeev M.	0001619841	Jan-25-2018	director
Quiroz Jorge Armando	0001727401	Jan-25-2018	officer: Chief Medical Officer
Zarur Juan Andrey	0001727404	Jan-25-2018	director
Ziolkowski Jennifer Lynn	0001727410	Jan-25-2018	officer: See Remarks
Stone Adam Leo	0001727440	Jan-25-2018	director
Ganot Ilan	0001727460	Jan-25-2018	director, officer: Chief Executive Officer
Amorrortu Pedro Alvaro	0001727552	Jan-25-2018	officer: Chief Operating Officer
Morris Carl Ashley	0001727571	Jan-25-2018	officer: Chief Scientific Officer
Sullivan Lynne Marie	0001727640	Jan-25-2018	director
Schneider Joel Solomon Zev	0001727649	Jan-25-2018	officer: See Remarks
Arnold Matthew Bennett	0001727991	Jan-25-2018	director, 10 percent owner
Hayeem Gilad David	0001728113	Jan-25-2018	director, 10 percent owner, officer: President
Huffines Robert Luther	0001728221	Jan-25-2018	director
JPMC Strategic Investments II Corp	0001728848	Jan-25-2018	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Solid Biosciences Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0001193125-26-116163 (33 Act) Size: KB	Mar-19-2026	333-294460 26775099
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0001193125-26-116158 (33 Act) Size: KB	Mar-19-2026	333-294456 26775079
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-26-115985 (33 Act) Size: KB	Mar-19-2026	333-294437 26774356
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001193125-26-115928 (34 Act) Size: KB	Mar-19-2026	001-38360 26774134
SCHEDULE 13D/A	Document	Acc-no: 0001104659-26-029671 (34 Act) Size: KB	Mar-17-2026	005-90280 26764095
8-K	Document	Current report filing Acc-no: 0001193125-26-102489 (34 Act) Size: KB	Mar-12-2026	001-38360 26744653
SCHEDULE 13D/A	Document	Acc-no: 0001193125-26-102083 (34 Act) Size: KB	Mar-11-2026	005-90280 26743168
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-102076 ( Act) Size: 0 KB	Mar-11-2026
SCHEDULE 13D/A	Document	Acc-no: 0001193125-26-100348 (34 Act) Size: KB	Mar-10-2026	005-90280 26740238
SCHEDULE 13D/A	Document	Acc-no: 0001346824-26-000070 (34 Act) Size: KB	Mar-10-2026	005-90280 26739908
8-K	Document	Current report filing Acc-no: 0001193125-26-096709 (34 Act) Size: KB	Mar-06-2026	001-38360 26731624
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-057878 ( Act) Size: 0 KB	Feb-18-2026
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001193125-26-057874 (33 Act) Size: 0 KB	Feb-18-2026	001-38360 26651343
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001193125-26-057873 (33 Act) Size: 0 KB	Feb-18-2026	001-38360 26651342
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-057872 ( Act) Size: 0 KB	Feb-18-2026
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001193125-26-057871 (33 Act) Size: 0 KB	Feb-18-2026	001-38360 26651340
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-057868 ( Act) Size: 0 KB	Feb-18-2026
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001193125-26-057867 (33 Act) Size: 0 KB	Feb-18-2026	001-38360 26651337
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001193125-26-057866 (33 Act) Size: 0 KB	Feb-18-2026	001-38360 26651336
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-057865 ( Act) Size: 0 KB	Feb-18-2026

Recent 20 filings. View all Solid Biosciences Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Solid Biosciences Inc. overview
Solid Biosciences Inc. job
Solid Biosciences Inc. stock
Solid Biosciences Inc. ownership
Solid Biosciences Inc. CEO
Solid Biosciences Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.